GlycoEra AG is advancing glycoengineered therapeutics to address unmet medical needs. Despite significant advancements in understanding the role of glycans in human health and diseases, this knowledge has not translated well into therapeutic drug development, a consequence of the limitations and complexities of controlling glycosylation processes. GlycoEra’s platform has overcome these challenges! The CustomGlycan Platform enables glycan-mediated modes of action through the engineering of highly defined specific glycan structures, accessing a novel combinatorial dimension for the treatment of very challenging diseases.
Get in touch with us if you would like to be part of this amazing new era in therapeutic drug development!
Employees: 11-50
Total raised: $49.74M
Founded date: 2020
Investors 1
| Date | Name | Website |
| 25.11.2021 | 5AM Ventur... | 5amventure... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.11.2021 | Series A | $49.74M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 08.01.2024 | Bristol Myers Squibb invests in GlycoEra | Bristol Myers Squibb (BMS) has joined GlycoEra’s list of investors supporting its mission to addre... | startuptic... |
| 12.05.2023 | Startups welcome seasoned industry leaders to their board | Insphero’s CEO Jan Lichtenberg has joined Scailyte’s board. The ETH Zürich spin-off developed a di... | startuptic... |
| 27.07.2022 | Startups rely on seasoned board members’ expertise | Sygnum, the world’s first digital asset bank, and a digital asset specialist with global reach has... | startuptic... |
| 09.05.2022 | C-Level managers for tech startups | Ganesh V. Kaundinya has assumed the role of President and Chief Executive Officer at GlycoEra, a b... | startuptic... |
| 12.11.2021 | GycoEra seals series A financing round at CHF 45 million | Founded as a spinoff of LimmaTech Biologics AG, GlycoEra has developed a game-changing glycoengine... | startuptic... |
| 08.11.2021 | GlycoEra gathers €43M Series A | Swiss startup GlycoEra has raised 45 million Swiss francs (about €43 million) in a round co-led by 5... | pitchbook.... |
| 05.11.2021 | GlycoEra AG Raises CHF 45 Million (US$ 49 Million) Series A ... | GlycoEra AG announced today the close of a CHF 45 million ($49 million) Series A financing round, co... | marketscre... |
| 05.11.2021 | A Chinese COVID Delta variant vaccine maker gets a boost | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 19.01.2021 | LimmaTech launches spin-out for drug development | GlycoEra has obtained a world-wide exclusive license from LimmaTech to its CustomGlycan Platform and... | startuptic... |
| 19.01.2021 | LimmaTech launches spin-out for drug development | GlycoEra has obtained a world-wide exclusive license from LimmaTech to its CustomGlycan Platform a... | startuptic... |